Publication Director: Graziano ManciantiRegistration at the Court in Florence Nr 6031 on September 6th 2016

DEKA 3DEKAA year of significant change

MONALISA TOUCH5 years of experimentation

DEKA DOC CONTESTThe winners

mag

Editorial

The theme of this, the third issue of DEKA MAG, is change and evolution. These concepts make it possible to achieve constant innovation and come up with new ideas, an approach which has underpinned our corporate mission since we began.

If it’s going to be successful, a business has to make sure to constantly evolve and develop in response to the changing demands of the industry and its customers. Continuous development of new products and services is the lifeblood of any business that is going to stand the test of time.

In the medical laser industry, change is crucial. New technologies and new applications come onto the market thick and fast and it’s part of our job to make sure that happens regularly.

Today, we’re proud to introduce you to our latest breakthroughs in terms of applications and to mention a few of the new products we’re testing.

After opening up a whole new market with MonaLisa Touch® treatment, we’re now expanding that. The use of the CO2 laser in gynaecology and female urology is turning out to be an effective and revolutionary tool, not only for the treatment of vaginal atrophy and dryness, but also for other symptoms that many women in the world suffer from, such as urinary incontinence, vestibulodynia, and lichen sclerosus.

The Motus AX range has given plenty of satisfaction in the way of sales and customer appreciation, and we will soon be announcing new ideas in the wake of the many opportunities this new method offers.

In our laboratories, we have also been testing a revolutionary new technology for the treatment of localized fat and cellulite deposits, details of which we will soon be announcing.

Change also involves the organizational side of the company – we are about to begin a restructuring process aimed at optimizing the whole chain, from design to production, to the marketing of our products.

Evolution and change are part of our heritage, and they are the main ingredients in any organization that is truly planning for the future!

Enjoy your read!

Mauro GalliInternational Sales and Marketing Director

1Editorial

Mauro GalliInternational Sales

and Marketing Director

2Breaking news

A yearof significant changes

3Cool stuffMonaLisa Touch®:

5 years of experimentation

4DOT/RF Therapy:

the most innovative frontier in antiaging treatment

5Eyes

on the marketSpotlight on

Japan

6Inside DEKA

DEKA Doc Contest

7Not

to miss | eventsImportant appointments

to participate

Summary

DEKAmag

Breaking news

After 2016, a year in which we posted record results, 2017 is proving to be a year of transi-tion and change.

A process of renewal has begun both internally and externally, explains El.En. General Manager Paolo Salvadeo.

From an in-house point of view, a corporate reorganization has begun, looking to maximize co-ordination and create product synergies and economies of scale that, in turn, will lead to cost benefits and thus enable us to compete more effectively in the global market.

From an external point of view, our distribution network received a boost recently with an important new player joining our ranks: Hologic, an American colos-sus in the women’s health sec-tor, who took over the distribu-tion of MonaLisa Touch in the USA and Canada. Hologic has an almost 60-year history of mak-ing diagnostic, gynaecological and oncological surgical tools. An undisputed leader in the gynaecology sector, with a wealth of market knowledge. It goes without saying that this is a great opportunity for DEKA, one

DEKA 2017

DEKA - A YEAROF SIGNIFICANT CHANGES

that will further boost the pres-ence and help expand MonaLisa Touch across North America, where the vaginal rejuvenation market is showing very interesting growth prospects. Hologic CEO, Stephen P. MacMillan, says Hologic’s acquisition of Cynosure “will turbo charge sales for the DEKA MonaLisa Touch® in North America”.

Also from a marketing point of view, we have significant news. Responding to an increasing need for minimally invasive surgical solutions for localized fat and cel-lulite deposits, here at DEKA we are currently designing a highly innovative technology that will be launched on the European market by 2018. Experimentation and clinical trials are under way to fine-tune the technology, but we are delighted to announce that the system will introduce effective improvements for patients, but also significant benefits for the physicians and practitioners who will be using it.

DEKA has always been an innova-tion leader, and the goal we have set is to maintain and consolidate this through cross fertilization, R&D investment, better coordi-nation and sounder awareness of

market needs. A future full of new challenges and commitments awaits us, and we are coming up with the right tools to deal with them!

Paolo SalvadeoEl.En. Group General Manager

3

Cool stuff

The wonder of laser technology lies in continuous experimenta-tion. The more widespread one of our systems becomes in the market (and therefore more widely-used), the more we’ll be able to come up with fascinating, revolutionary new applications.

In the 5 years since MonaLisa Touch was launched, experimentation has kept moving forward, and we are increasingly recognizing the huge potential this application has in the gynaecology sector. Indeed, we have opened up a pathway that looks set to bring plenty of benefits to the world of medicine as a whole.

New Gynaecological Applications

MONALISA TOUCH ®:5 YEARS OF EXPERIMENTATION

The treatment of vulvovaginal atro-phy (VVA) in menopausal women or women with neoplasia remains the core treatment. In addition to VVA, CO2 laser treatment has also proven effective at treating mild urinary stress incontinence. A study by Perino et al, published in the European Review for Medical and Pharmacological Sciences, showed that after treating 30 post-menopausal women, a significant reduction in daily urinary frequency was observed.

Positive results have also been obtained regarding bacterial flora. In their study published in Climacteric, Athanasiou et al demonstrated that,

after MonaLisa Touch ® treatment in a cohort of 53 patients, the presence of lactobacilli rose by 50 percentage points, while no symptoms of bacterial vaginosis, candidiasis or aerobic vaginitis appeared in any of the participants.

One very important new applica-tion is for vestibulodynia. Chronic vulvar pain remains one of the most complex problems faced by gynaecologists today. Murina et al demonstrated in a clinical study published in SEX MED, that after 3 sessions of MonaLisa Touch 70% of patients reported significant pain relief.

Another common, highly complex disorder is lichen sclerosus.Baggish has continued research in this field, showing that women with lichen have reported cessa-tion of itching and pain, as well as improvements in terms of tis-sue colour and elasticity.

This is a sector which remains rather untapped for reasons mainly connected both with physi-cians’ lack of familiarity with pro-cedures and with a predominant attitude of resignation on the part of patients; but we are confident that this will change and so we are con-tinuing to invest!

®

The effects of the CO2 laser on the vaginal mucosa

and vulvar tissue are surprising, such that we

are now witnessing a true revolution in women’s

health.

mild urinary stressincontinence

•bacterial flora

•vestibulodynia

•lichen

sclerosus

DEKAmag

Cool stuff

Physiological aging, linked to the passing of time, is a natural and inevitable aspect of life that affects all the functions, organs and tissues of the human body, including the skin.

This natural process is accelerated by external environmental fac-tors (ultraviolet rays, smoke, alcohol, pollution, etc.), which make up what is known as photoaging. The clinical effects include thinning, transparency and sagging of the skin, wrinkles, uneven colouring, pigmentary and vas-cular marks and irregularities in the skin surface.

The research into technological innovation has started many time ago but it’s still very dynamic since the demand for improvements in appearance and quality of life is increasing.

The sinergic action of CO2 laser with RF is a very effective solution because allows to obtein a high degree of efficacy with shorter post-treatment recovery times. It can selectively reach all the layers of the skin, corrects skin imperfections and counteracts the effects of aging, such as wrinkles and flabbiness.

The RF bipolar technology activate a selective heating of the derma, completing and enhancing the effects of CO2 laser treatment by remodeling tissue in depth, toning flabbiness, and stimulate fibroblast activity to produce new collagen. The combined ac-tion of CO2 and RF reduces post-treatment erythema and downtime with great benefits for the patients.

Dermatologyand new mini-invasive procedures

DOT/RF THERAPY:THE MOST INNOVATIVE FRONTIER IN ANTIAGING TREATMENT

FOCUS ON

Over recent years, the market has been focusing increasingly on less

invasive systems and methods. DEKA has replied to this trend with the

new DOT/RF Therapy, an innovative procedure that exploit the exclusive combined action of fractional CO2

laser with radiofrequence.

The SmartXide² DOT RF continues to be a major player in today’s competitive market, it is the result of 30 years of know how that allowed to achieves

performance level never attained before.

3

Eyes on the marketThis section is dedicated to unveil the world of DEKA’s distributors to get insights that inspire action and know the key drivers better…

Japan

trend as a novel UVB therapy in 2009, the efficacy of the therapy, which is an essential treatment method which secures payment for the service, has been rated higher than conventional narrow band therapy. That has contributed to increasing the sales of the device.

Anyway today the cosmetic medical treatment related to dermatol-ogy and plastic surgery, as the whole market - has been stagnant. Our competitors have also been exposed to difficult situations including fierce price competition. Today the field which is drawing attention is the vaginal laser rejuvenation. That’s why in the last 3 years we have been focus-ing our promotional efforts of MonaLisa Touch® application in the obstetrics and gynecology field, which has started to enhance the recognition of the company as well as the product among gynecol-ogists, successfully increasing the sales performance.

Spotlight on

Mariko YukiPresident ofDEKA Japan Co. LtdTokyo (Japan)

At the time it was established, in 2009, DEKA JAPAN was a nameless laser manufacturer company. But during the years this company has significantly increased the sales performance till to become a widely recognized laser company, which has enabled it to be established as one of the leading laser manufacturers.

The successfully performances are due mostly to 2 hits products: Madonna Lift using SmartXide DOT and Excilite-µ.

Madonna Lift is a fractioned CO2 laser procedure which treats the wrinkles and saggy, lax skin around the eyes. It is a novel modal proposed to target the areas which had been difficult to treat with traditional therapy such as laser and injection. Celebrity marketing which introduced Madonna has proved to be effective to create a buzz and promote its recognition among patients and doctors, successfully increased the sales promotion. EXCILITE-µ, a targeted UV device, has been increasingly introduced into dermatology. Along with the fact that the device became a

DEKAmag

Inside DEKA

DEKADOCContest

Download DEKA App

The DEKA DOC Contest, the event which pitched laser profession-als from around the world against each other, has been a great suc-cess. A whole host of participants enrolled, with a vast array of clini-cal cases being made available to the scientific community.

For that reason, we would very much like to thank all those who took part. We firmly believe in the value of comparing and sharing results, as we have found that they provide a basis for achieving excellence.

Cases with the most votes were then assessed by the Scientific Committee, which chose the Best Clinical Case, based on scientific merit and interest.

The 4 winners are highlighted on the dekadoccontest.dekalaser.com website and the clinical cases will be collated in an official docu-ment and published online (DEKA website and APP).

We would like to thank everyone who signed up, who submitted cases or who just voted on their colleagues’ work. It was a very suc-cessful initiative and we hope it will make a great contribution to the widespread use of lasers in medicine.

... WE ARE ALREADY PLANNING THE SECOND EDITION!

Latest Update

BEST CLINICAL CASE

First prize € 2500

Winner Dr. Wildecir Barros with his case studyentitled “Diabetic Foot”

Total score: 9/10The Scientific Committee appreciated not only the complexity of the case and the result achieved, but also the profound knowledge of laser use that he demonstrated.

BEST AUTHORS

• Firstplace€2000

Winner Dr. Gema Perez Sevilla for publishing the highest

number of quality cases.

Total score 24 points

• Secondplace€1500

Winner Dr. Dilla Mazzaracchio

Total score 16 points

• Third place € 1000

Winner Dr. Yuliya Kolas

Total score 8 points

3

Not to miss | events

Biannual Magazine Year 2 - number 2/2017

Publication DirectorGraziano ManciantiJournalist

Owner and PublisherDEKA M.E.L.A. s.r.l.Via Baldanzese, 17 50041 Calenzano (FI)

Registration at the Court in FlorenceNr 6031 on September 6th 2016

TypographyLionGrafVia Dante Alighieri, 850041 Calenzano (FI)

Graphic projects and LayoutAllymind

Contactsdekamag@dekalaser.com Ph. +39 055 8874942 Fax +39 055 8832884www.dekalaser.com

All the articles published can be reproducedwith the authorization of the Publisherand citing the source.

DEKA M.E.L.A. s.r.l.Via Baldanzese, 1750041 Calenzano (FI) - ItalyPh. +39 055 8874942Fax +39 055 8832884info@dekalaser.comwww.dekalaser.com

3

Follow us on

www.dekalaser.com

DEKAmag

Arab Health

Dubai (United Arab Emirates)29 January-1 February 2018Dubai International Conventionand Exhibition CenterPavilion ItalyDEKA STAND B15 - Rashid Hall

IMCAS Parigi20th Annual World Congress

Paris (France)1-3 February 2018Palais de CongrèsDEKA STAND 14

AADAmerican Academy of DermatologyAnnual meeting

San Diego (USA )16-18 February 2018San Diego Convention CenterDEKA STAND 1645

DEKA Academy

Villa DonatelloFlorence (Italy)•Nd:YAG e CO2 lasers 12-13 October 2017 8-9 February 2018 8-9 March 2018

EADV26th European Academyof Dermatology and Venerology

Geneve (Switzerland)13-17 September 2017PalexpoDEKA STAND 200

ESG12th Congress of EuropeanSociety of Gynecology

Barcelona, (Spain)18-21 October 2017Palau de Congressos de CatalunyaDEKA STAND 19-20

EUGA10th Congress of European Urogynaecological Association

Barcelona (Spain)19-21 October 2017Crowne Plaza Fira CenterDEKA STAND 11

XXII Congreso Latinoamericanode Ginecologìa y ObstetriciaFLASOG 2017

Cancun (Mexico)5-9 November 2017Cancun ICC InternationalConvention CenterDEKA STAND 40

AMWC Latin AmericaAesthetic & Anti-Aging MedicineWorld Congress

Medellin (Colombia)16-18 November 2018Plaza Mayor ConvencionesDEKA STAND 13